Literature DB >> 26130715

The XRCC1 phosphate-binding pocket binds poly (ADP-ribose) and is required for XRCC1 function.

Claire Breslin1, Peter Hornyak1, Andrew Ridley1, Stuart L Rulten1, Hana Hanzlikova1, Antony W Oliver1, Keith W Caldecott2.   

Abstract

Poly (ADP-ribose) is synthesized at DNA single-strand breaks and can promote the recruitment of the scaffold protein, XRCC1. However, the mechanism and importance of this process has been challenged. To address this issue, we have characterized the mechanism of poly (ADP-ribose) binding by XRCC1 and examined its importance for XRCC1 function. We show that the phosphate-binding pocket in the central BRCT1 domain of XRCC1 is required for selective binding to poly (ADP-ribose) at low levels of ADP-ribosylation, and promotes interaction with cellular PARP1. We also show that the phosphate-binding pocket is required for EGFP-XRCC1 accumulation at DNA damage induced by UVA laser, H2O2, and at sites of sub-nuclear PCNA foci, suggesting that poly (ADP-ribose) promotes XRCC1 recruitment both at single-strand breaks globally across the genome and at sites of DNA replication stress. Finally, we show that the phosphate-binding pocket is required following DNA damage for XRCC1-dependent acceleration of DNA single-strand break repair, DNA base excision repair, and cell survival. These data support the hypothesis that poly (ADP-ribose) synthesis promotes XRCC1 recruitment at DNA damage sites and is important for XRCC1 function.
© The Author(s) 2015. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26130715      PMCID: PMC4538820          DOI: 10.1093/nar/gkv623

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  45 in total

1.  The region of XRCC1 which harbours the three most common nonsynonymous polymorphic variants, is essential for the scaffolding function of XRCC1.

Authors:  Audun Hanssen-Bauer; Karin Solvang-Garten; Karin Margaretha Gilljam; Kathrin Torseth; David M Wilson; Mansour Akbari; Marit Otterlei
Journal:  DNA Repair (Amst)       Date:  2012-01-26

2.  Topoisomerase I poisoning results in PARP-mediated replication fork reversal.

Authors:  Arnab Ray Chaudhuri; Yoshitami Hashimoto; Raquel Herrador; Kai J Neelsen; Daniele Fachinetti; Rodrigo Bermejo; Andrea Cocito; Vincenzo Costanzo; Massimo Lopes
Journal:  Nat Struct Mol Biol       Date:  2012-03-04       Impact factor: 15.369

3.  Direct interaction between XRCC1 and UNG2 facilitates rapid repair of uracil in DNA by XRCC1 complexes.

Authors:  Mansour Akbari; Karin Solvang-Garten; Audun Hanssen-Bauer; Nora Valeska Lieske; Henrik Sahlin Pettersen; Grete Klippenvåg Pettersen; David M Wilson; Hans E Krokan; Marit Otterlei
Journal:  DNA Repair (Amst)       Date:  2010-05-13

4.  PARP-3 and APLF function together to accelerate nonhomologous end-joining.

Authors:  Stuart L Rulten; Anna E O Fisher; Isabelle Robert; Maria C Zuma; Michele Rouleau; Limei Ju; Guy Poirier; Bernardo Reina-San-Martin; Keith W Caldecott
Journal:  Mol Cell       Date:  2011-01-07       Impact factor: 17.970

5.  PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination.

Authors:  Helen E Bryant; Eva Petermann; Niklas Schultz; Ann-Sofie Jemth; Olga Loseva; Natalia Issaeva; Fredrik Johansson; Serena Fernandez; Peter McGlynn; Thomas Helleday
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

Review 6.  Single-strand break repair and genetic disease.

Authors:  Keith W Caldecott
Journal:  Nat Rev Genet       Date:  2008-08       Impact factor: 53.242

7.  Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate.

Authors:  Cecilia E Ström; Fredrik Johansson; Mathias Uhlén; Cristina Al-Khalili Szigyarto; Klaus Erixon; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2010-12-22       Impact factor: 16.971

8.  XRCC1 coordinates disparate responses and multiprotein repair complexes depending on the nature and context of the DNA damage.

Authors:  Audun Hanssen-Bauer; Karin Solvang-Garten; Ottar Sundheim; Javier Peña-Diaz; Sonja Andersen; Geir Slupphaug; Hans E Krokan; David M Wilson; Mansour Akbari; Marit Otterlei
Journal:  Environ Mol Mutagen       Date:  2011-07-22       Impact factor: 3.216

9.  The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1.

Authors:  Youngsoo Lee; Sachin Katyal; Yang Li; Sherif F El-Khamisy; Helen R Russell; Keith W Caldecott; Peter J McKinnon
Journal:  Nat Neurosci       Date:  2009-07-26       Impact factor: 24.884

10.  PARP-1 ensures regulation of replication fork progression by homologous recombination on damaged DNA.

Authors:  Kazuto Sugimura; Shin-Ichiro Takebayashi; Hiroshi Taguchi; Shunichi Takeda; Katsuzumi Okumura
Journal:  J Cell Biol       Date:  2008-12-22       Impact factor: 10.539

View more
  47 in total

1.  Triptolide induces DNA breaks, activates caspase-3-dependent apoptosis and sensitizes B-cell lymphoma to poly(ADP-ribose) polymerase 1 and phosphoinositide 3-kinase inhibitors.

Authors:  Jiawei Guan; Qian Zhao; Jian Lv; Zhiwei Zhang; Shijie Sun; Weifeng Mao
Journal:  Oncol Lett       Date:  2017-08-18       Impact factor: 2.967

2.  Lysines in the lyase active site of DNA polymerase β destabilize nonspecific DNA binding, facilitating searching and DNA gap recognition.

Authors:  Michael J Howard; Julie K Horton; Ming-Lang Zhao; Samuel H Wilson
Journal:  J Biol Chem       Date:  2020-07-09       Impact factor: 5.157

Review 3.  Coordination of DNA single strand break repair.

Authors:  Rachel Abbotts; David M Wilson
Journal:  Free Radic Biol Med       Date:  2016-11-24       Impact factor: 7.376

Review 4.  Poly(ADP-Ribosylation) in Age-Related Neurological Disease.

Authors:  Leeanne McGurk; Olivia M Rifai; Nancy M Bonini
Journal:  Trends Genet       Date:  2019-06-07       Impact factor: 11.639

Review 5.  Poly-ADP ribosylation in DNA damage response and cancer therapy.

Authors:  Wei-Hsien Hou; Shih-Hsun Chen; Xiaochun Yu
Journal:  Mutat Res Rev Mutat Res       Date:  2017-09-20       Impact factor: 5.657

6.  Poly (ADP) Ribose Glycohydrolase Can Be Effectively Targeted in Pancreatic Cancer.

Authors:  Lebaron C Agostini; Grace A McCarthy; Aditi Jain; Saswati N Chand; AnnJosette Ramirez; Avinoam Nevler; Joseph Cozzitorto; Christopher W Schultz; Cinthya Yabar Lowder; Kate M Smith; Ian D Waddell; Maria Raitses-Gurevich; Chani Stossel; Yulia Glick Gorman; Dikla Atias; Charles J Yeo; Jordan M Winter; Kenneth P Olive; Talia Golan; Michael J Pishvaian; Donald Ogilvie; Dominic I James; Allan M Jordan; Jonathan R Brody
Journal:  Cancer Res       Date:  2019-07-04       Impact factor: 12.701

7.  AI26 inhibits the ADP-ribosylhydrolase ARH3 and suppresses DNA damage repair.

Authors:  Xiuhua Liu; Rong Xie; Lily L Yu; Shih-Hsun Chen; Xiaoyun Yang; Anup K Singh; Hongzhi Li; Chen Wu; Xiaochun Yu
Journal:  J Biol Chem       Date:  2020-08-04       Impact factor: 5.157

Review 8.  NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential.

Authors:  Na Xie; Lu Zhang; Wei Gao; Canhua Huang; Peter Ernst Huber; Xiaobo Zhou; Changlong Li; Guobo Shen; Bingwen Zou
Journal:  Signal Transduct Target Ther       Date:  2020-10-07

9.  Characterization of the APLF FHA-XRCC1 phosphopeptide interaction and its structural and functional implications.

Authors:  Kyungmin Kim; Lars C Pedersen; Thomas W Kirby; Eugene F DeRose; Robert E London
Journal:  Nucleic Acids Res       Date:  2017-12-01       Impact factor: 16.971

10.  Kinetics of poly(ADP-ribosyl)ation, but not PARP1 itself, determines the cell fate in response to DNA damage in vitro and in vivo.

Authors:  Harald Schuhwerk; Christopher Bruhn; Kanstantsin Siniuk; Wookee Min; Suheda Erener; Paulius Grigaravicius; Annika Krüger; Elena Ferrari; Tabea Zubel; David Lazaro; Shamci Monajembashi; Kirstin Kiesow; Torsten Kroll; Alexander Bürkle; Aswin Mangerich; Michael Hottiger; Zhao-Qi Wang
Journal:  Nucleic Acids Res       Date:  2017-11-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.